Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-10-30
2000-05-02
McKane, Joseph K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514 85, 544337, 544358, 544359, 544360, 544372, 544383, 544386, 544387, 544389, A61K 31495, C07D24104
Patent
active
060573236
ABSTRACT:
Compounds having kappa opioid agonist activity, compositions containing them and method of using them as analgesics and anti-pruritic agents are provided.
The compound of formula I, having the structure: ##STR1## wherein R.sub.1, R.sub.2 ;
REFERENCES:
patent: 4065573 (1977-12-01), Lednicer
patent: 4098904 (1978-07-01), Szmuszkovicz
patent: 4145435 (1979-03-01), Szmuszkovicz
patent: 4212878 (1980-07-01), Lednicer et al.
patent: 4359476 (1982-11-01), Kaplan et al.
patent: 4438130 (1984-03-01), Kaplan
patent: 4663343 (1987-05-01), Horwell et al.
patent: 4855316 (1989-08-01), Horwell et al.
patent: 4906655 (1990-03-01), Horwell et al.
patent: 5646151 (1997-07-01), Kruse et al.
patent: 5688955 (1997-11-01), Kruse et al.
patent: 5744458 (1998-04-01), Kruse et al.
McMahon et al., TINS, vol. 15, No. 12 (1992).
Bernstein et al., Journal of Investigative Dermatology, 78: 82-83 (1982).
Ballantyne et al., Pain, 33: 149-160 (1988).
J. D. Bernhard, J. Am. Acad. Derm. 24: 309 (1991).
IASP Newsletter, Sep./Oct. 1996.
Thomas et al., Brain Research, 695:267-270 (1995).
Chang An-Chih
Gaul Forrest
Guo Deqi
Kumar Virendra
Marella Michael Anthony
Adolor Corporation
Balogh Imre
McKane Joseph K.
LandOfFree
Kappa agonist compounds pharmaceutical formulations and method o does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Kappa agonist compounds pharmaceutical formulations and method o, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kappa agonist compounds pharmaceutical formulations and method o will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1594041